Category: Biopharmaceuticals
Europe Biopharmaceuticals
-
Herceptin Biosimilar Market, by Indication (Breast Cancer, Gastric Cancer, and Others), by Distribution Channel (Hospital, Oncology Centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Sh
... Share, Outlook, and Opportunity Analysis, 2022 - 2028 Trastuzumab, sold under the brand Herceptin, is a monoclonal antibody used for the treatment of breast cancer and gastric cancer. Herceptin is mainly used to treat patients ... Read More
-
GMP Cell Banking Services Market, By Cell Type (Mammalian, Microbial, Insect, Yeast, Avian, Stem Cell Type, Others), By End User (Biopharmaceutical Companies, Contract Manufacturing Organizations), and By Region (North America, Latin America, Europe, Asia
... Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 GMP cell banking services is termed as the storing of cells of specific genome for the purpose of future use in ... Read More
-
Europe Biopharmaceutical Contract Manufacturing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Biologics and Biosimilar), Service (Process Development, Fill and Finish Operation, Analytical and QC Studies, and Packaging), and Source (Mammalian and Microbial-Based Biologics/Non-Mammalian)
... and Microbial-Based Biologics/Non-Mammalian) The biopharmaceutical contract manufacturing market in Europe is expected to grow from US$ 4,610.37 million in 2021 to US$ 8,026.13 million by 2028; it is estimated to register a CAGR of 8.2% ... Read More
-
Europe Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... and Biosimilar antibody products) The Europe next-generation antibody market is expected to reach US$ 3,162.30 million by 2028 from US$ 1,455.32 million in 2021. It is estimated to grow at a CAGR of 11.7% from ... Read More
-
Global Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Generic Drugs Market ... Read More
-
Healthcare Cold Chain Monitoring Market: Information by Component (Hardware (Sensors, Data Loggers, Real-Time Monitoring Devices, RFID Devices, Resistance Temperature Detectors, and Others), Software (Cloud Based and On-Premises),Temperature Type (Frozen and Chilled), Product (Vaccines, Biopharmaceuticals, Clinical Trial Materials, and Others),End-User (Biopharmaceutical Companies, Hospital & Clinics, Research Institutes, and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2027
... Trial Materials, and Others),End-User (Biopharmaceutical Companies, Hospital & Clinics, Research Institutes, and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2027 Healthcare Cold Chain Monitoring Market—Forecast till 2027 Market Overview ... Read More
-
Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis Optica and Paroxysmal Nocturnal Hemoglobinuria), Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Oral and Subcutaneous), Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035
... Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route ... Read More
-
Single Use Products in Biopharmaceuticals Market, by Product Type {(Work Equipment [Flask, Containers, Syringes, Pipettes tips, Centrifuge tubes, Hand Gloves, Face Mask, Filters, Tubes, Others]), by Apparatus (Single Use Bioreactor, Isolators, Membrane Valves, Canister, Chromatography Systems, Filtration Systems, Mixing Systems, and Others)}, by End User (Pharmaceutical Companies, Biotechnology Companies and Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Systems, Filtration Systems, Mixing Systems, and Others)}, by End User (Pharmaceutical Companies, Biotechnology Companies and Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, ... Read More
-
Europe Bioprocess Containers Market By Type (2D Bioprocess Containers, 3D Bioprocess Containers, and Other Containers & Accessories), By Application (Upstream Processes, Downstream Processes and Process Development), By End User (Pharmaceutical & Biopharmaceutical Companies, Academic & Research Institutes and CROs & CMOs), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
... Research Institutes and CROs & CMOs), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027 The Europe Bioprocess Containers Market would witness market growth of 25.7% CAGR during the forecast period (2021-2027). The use ... Read More
-
Europe Healthcare Digital Experience Platform Market By Component (Platform (without services), and Services), By Application (Business-to-Consumer (B2C), Business-to-Business (B2B), and Others), By Delivery Mode (Cloud and On-premise), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
... - 2027 The Europe Healthcare Digital Experience Platform Market would witness market growth of 12.0% CAGR during the forecast period (2021-2027). For instance, cloud enablement can make life lot simpler for a hospital. A hospital ... Read More
Research Assistance
